Ad is loading...
FSENX vs ICPAX
FSENX vs ICPAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FSENX vs. ICPAX commentary
Jan 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSENX is a Buy and ICPAX is a Buy.
FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 1.92B vs. ICPAX (135M). FSENX pays higher dividends than ICPAX: FSENX (1.72) vs ICPAX (1.15). FSENX was incepted earlier than ICPAX: FSENX (44 years) vs ICPAX (26 years). FSENX (43.00) and ICPAX (41.75) have comparable annual turnover. FSENX has a lower initial minimum investment than ICPAX: FSENX (0) vs ICPAX (1000). ICPAX annual gain was more profitable for investors over the last year : 38.77 vs. FSENX (18.69). FSENX return over 5 years is better than : 98.64 vs. ICPAX (67.14).
| FSENX | ICPAX | FSENX / ICPAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 44 years | 26 years | - |
| Gain YTD | 8.628 | 10.374 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.92B | 135M | 1,425% |
| Annual Yield % from dividends | 1.72 | 1.15 | 149% |
| Returns for 1 year | 18.69 | 38.77 | 48% |
| Returns for 3 years | 58.97 | 53.53 | 110% |
| Returns for 5 years | 98.64 | 67.14 | 147% |
| Returns for 10 years | 62.31 | 30.06 | 207% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FERIX | 48.89 | 0.64 | +1.33% |
| Fidelity Advisor Emerging Asia I | |||
| FGIRX | 42.36 | 0.35 | +0.83% |
| Fidelity Advisor Growth & Income A | |||
| JIEZX | 18.69 | 0.09 | +0.48% |
| JPMorgan International Equity R2 | |||
| MSBQX | 11.74 | 0.03 | +0.26% |
| Morgan Stanley American Resilience R6 | |||
| RCGHX | 16.49 | N/A | N/A |
| Virtus KAR Health Sciences C | |||